Skip to main content
OpenTrials

Clinical trial condition

Myelodysplastic Syndromes

Explore clinical trials studying Myelodysplastic Syndromes. Study availability and eligibility vary by location and protocol.

1,362 public trials 239 recruiting studies
Refine in advanced search Browse all conditions

Myelodysplastic Syndromes trial results

Completed

Pevonedistat and Azacitidine in MDS or MDS/MPN Patients Who Fail Primary Therapy With DNA Methyl Transferase Inhibitors

NCT03238248

Conditions
Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +3 more
Locations
  • University of Miami Miller School of Medicine Miami, Florida, United States
  • University of Kansas Cancer Center Westwood, Kansas, United States
  • Memorial Sloan-Kettering New York, United States
  • University of Rochester Medical Center Rochester, New York, United States
View Trial Details
Completed

Phase 1/2 Study of Enasidenib (AG-221) in Adults With Advanced Hematologic Malignancies With an Isocitrate Dehydrogenase Isoform 2 (IDH2) Mutation

NCT01915498

Conditions
Bone Marrow Diseases, Hematologic Diseases, Hematologic Neoplasms, +8 more
Locations
  • City Of Hope Duarte, California, United States
  • Stanford Cancer Center Stanford, California, United States
  • University Of Colorado Cancer Center Aurora, Colorado, United States
  • University of Miami Sylvester Cancer Center Miami, Florida, United States
View all 24 locations
View Trial Details
Completed

Cytomegalovirus (CMV) Vaccine in Donors and Recipients Undergoing Allogeneic Hematopoietic Cell Transplant (HCT)

NCT00285259

Conditions
Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, Bone Marrow Diseases, +37 more
Locations
  • Arizona Cancer Center Tucson, Arizona, United States
  • City of Hope National Medical Center Duarte, California, United States
  • Rocky Mountain Cancer Center Denver, Colorado, United States
  • University of South Florida Tampa, Florida, United States
View all 22 locations
View Trial Details
Completed

An Efficacy and Safety Study of Luspatercept (ACE-536) for the Treatment of Anemia Due to IPSS-R Very Low, Low or Intermediate Risk Myelodysplastic Syndromes (MDS) in Japanese Subjects Who Are Not Requiring Red Blood Cell Transfusion

NCT03900715

Conditions
Anemia, Bone Marrow Diseases, Hematologic Diseases, +2 more
Locations
  • Local Institution - 338 Matsuyama, Ehime, Japan
  • Local Institution - 344 Nagasaki, Japan
  • Local Institution - 336 Sayama, Osaka, Japan
  • Local Institution - 345 Chiba, Japan
View all 19 locations
View Trial Details
Completed

Safety and Efficacy Study of CC-486 in Subjects With Myelodysplastic Syndromes

NCT02281084

Conditions
Bone Marrow Diseases, Bronchial Diseases, Bronchiolitis, +12 more
Locations
  • Local Institution - 113 New Haven, Connecticut, United States
  • Yale University New Haven, Connecticut, United States
  • University of Miami Miller School of Medicine Miami, Florida, United States
  • H Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States
View all 89 locations
View Trial Details
Completed

A Dose Escalation Study to Investigate the Safety, Pharmacokinetics (PK), Pharmacodynamics (PD) and Clinical Activity of GSK525762 in Subjects With Relapsed, Refractory Hematologic Malignancies

NCT01943851

Conditions
Blood Protein Disorders, Bone Marrow Diseases, Cardiovascular Diseases, +19 more
Locations
  • GSK Investigational Site Little Rock, Arkansas, United States
  • GSK Investigational Site Aurora, Colorado, United States
  • GSK Investigational Site New York, United States
  • GSK Investigational Site Philadelphia, Pennsylvania, United States
View all 15 locations
View Trial Details

Related conditions